InvestorsHub Logo
icon url

GD

08/16/20 1:44 PM

#32915 RE: boozeman #32913

Yes, very interesting view of "You’ll get FDA approval because the bar is
so low these days. You’ll get snapped up by some big pharma mostly to
acquire the IP and bring development in house to avoid you getting lucky
and stumbling on something useful and profitable so they dont miss out
and avoid another AMGEN." Me too: "Come on Geert, shock the world......PLEASE!",
and prove my bullish case of PR presenting at ESMO is right next week!!!